{
  "id": 14969990,
  "title": "Piper Sandler lowers Home Bancshares price target to $34 on growth",
  "url": "https://urgent.news/2026/10/16/piper-sandler-lowers-home-bancshares-price-target-to-34-on-growth",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T14:10:48.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/piper-sandler-lowers-home-bancshares-price-target-to-34-on-growth-93CH-4954392"
  },
  "original_language": "en",
  "account": "Piper Sandler has revised its price target for Home Bancshares stock (NYSE:HOMB) downward to $34, down from $36, while keeping an Overweight rating. The firm's third-quarter 2026 results exceeded expectations, with earnings per share surpassing estimates by $0.02. This improvement was driven by increased net interest income and no provisions. However, the bank experienced a decline in loans by 5.0% and total deposits by 7.5% on an annualized quarter-over-quarter basis. Piper Sandler has adjusted its 2026 earnings per share estimate to $2.50, unchanged from the previous estimate, and raised its projections for 2027 and 2028 to $2.54 and $2.66, respectively. The price target of $34 translates to approximately 12.5 times the 2027 earnings estimate, taking into account the additional value from excess capital. Analysts remain optimistic about Home Bancshares' prospects, noting its profitability and high-quality status, supported by an 11% return on equity and a current P/E ratio of 11.86. The investment firm highlights that HOMB has consistently increased its dividend for 12 consecutive years, with a current yield of 3.19%. For investors seeking further analysis, the InvestingPro Tip suggests that the stock is undervalued, and a detailed Pro Research Report is available for HOMB and 1,400+ other US equities. Home Bancshares' latest earnings report, released recently, reported record third-quarter 2026 earnings of $129.1 million, or $0.65 per share, exceeding Wall Street's expectations. Despite the strong earnings, revenue fell short of estimates, with $288.4 million generated versus the anticipated $294.44 million. Analysts have commended Home Bancshares for maintaining robust capital levels and shareholder returns, even amidst revenue challenges, emphasizing the company's strong financial performance.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Piper Sandler raises Opko Health stock price target on LabCorp deal",
        "url": "https://urgent.news/2026/10/16/piper-sandler-raises-opko-health-stock-price-target-on-labcorp-deal",
        "published": "2026-10-16T14:10:49.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}